Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 6893-6905

  Buckwalter, Matthew R ^a,e   Nga, Phan Thi ^b   Gouilh, Meriadeg Ar ^a   Fiette, Laurence ^a   Bureau, Jean Francois ^a   Laird, Melissa E ^a,e   Buchrieser, Julian ^a   Ozden, Simona ^a   Cheval, Justine ^a,h   Eloit, Marc ^a,d   Manuguerra, Jean Claude ^a   Gessain, Antoine ^a   Brey, Paul T ^c   Fontanet, Arnaud ^a,g   Albert, Matthew L ^a,e,f  

^a INSTITUT PASTEUR   (France)

^b NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^c Institut Pasteur du Laos   (Laos)

^d ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^e INSERM   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g Unité de Recherches Mesures Physiques Métrologie   (France)

^h Pathoquest   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NERVE CELL NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYROSEQUENCING; SPINAL CORD INFECTION; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS STRAIN;

ANIMALIA; MIRIDAE; MURINAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 79960397170     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00274-11     Document Type: Article

References (45)

1. Aubert, C., and M. Brahic. 1995. Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J. Virol. 69, 3197-3200.
2. Aubert, C., M. Chamorro, and M. Brahic. 1987. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3, 319-326.
3. Bandyopadhyay, P. K., A. Pritchard, K. Jensen, and H. L. Lipton. 1993. A three-nucleotide insertion in the H stem-loop of the 5'untranslated region of Theiler's virus attenuates neurovirulence. J. Virol. 67, 3691-3695.
4. Bureau, J. F., et al. 1992. The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J. Virol. 66, 4698-4704.
5. Camacho, C., et al. 2009. BLAST+, architecture and applications. BMC Bioinformatics 10, 421.
6. Casals, J. 1963. Immunological characterization of Vilyuisk human encephalomyelitis virus. Nature 200, 339-341.
7. Chiu, C. Y., et al. 2008. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc. Natl. Acad. Sci. U. S. A. 105, 14124-14129.
8. Delhaye, S., V. van Pesch, and T. Michiels. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78, 4357-4362.
9. Fu, J. L., et al. 1990. Neurovirulence determinants of genetically engineered Theiler viruses. Proc. Natl. Acad. Sci. U. S. A. 87, 4125-4129.
10. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-Pdb-Viewer, an environment for comparative protein modeling. Electrophoresis 18, 2714-2723.
11. Huson, D. H., A. F. Auch, J. Qi, and S. C. Schuster. 2007. MEGAN analysis of metagenomic data. Genome Res. 17, 377-386.
12. Jarousse, N., et al. 1994. A single amino acid change determines persistence of a chimeric Theiler's virus. J. Virol. 68, 3364-3368.
13. Jones, M. S., V. V. Lukashov, R. D. Ganac, and D. P. Schnurr. 2007. Discovery of a novel human picornavirus in a stool sample from a pediatric patient presenting with fever of unknown origin. J. Clin. Microbiol. 45, 2144-2150.
14. Kim, B. S., et al. 1998. A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J. Virol. 72, 1020-1027.
15. Kong, W. P., and R. P. Roos. 1991. Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 65, 3395-3399.
16. Law, K. M., and T. D. Brown. 1990. The complete nucleotide sequence of the GDVII strain of Theiler's murine encephalomyelitis virus (TMEV). Nucleic Acids Res. 18, 6707-6708.
17. Lin, X., et al. 1998. Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J. Virol. 72, 1262-1269.
18. Lipton, H. L. 1980. Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J. Gen. Virol. 46, 169-177.
19. Lipton, H. L. 1975. Theiler's virus infection in mice, an unusual biphasic disease process leading to demyelination. Infect. Immun. 11, 1147-1155.
20. Lipton, H. L., A. S. Kumar, S. Hertzler, and H. V. Reddi. 2006. Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system. Glycoconj. J. 23, 39-49.
21. Lipton, H. L., G. Twaddle, and M. L. Jelachich. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69, 2525-2533.
22. Lole, K. S., et al. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73, 152-160.
23. Luo, M., C. He, K. S. Toth, C. X. Zhang, and H. L. Lipton. 1992. Threedimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. U. S. A. 89, 2409-2413.
24. Luo, M., K. S. Toth, L. Zhou, A. Pritchard, and H. L. Lipton. 1996. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 220, 246-250.
25. McAllister, A., F. Tangy, C. Aubert, and M. Brahic. 1990. Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J. Virol. 64, 4252-4257.
26. McCright, I. J., I. Tsunoda, F. G. Whitby, and R. S. Fujinami. 1999. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J. Virol. 73, 2814-2824.
27. Michiels, T., N. Jarousse, and M. Brahic. 1995. Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214, 550-558.
28. Ohsawa, K., Y. Watanabe, H. Miyata, and H. Sato. 2003. Genetic analysis of a Theiler-like virus isolated from rats. Comp. Med. 53, 191-196.
29. Pevear, D. C., et al. 1988. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 165, 1-12.
30. Posada, D. 2008. jModelTest, phylogenetic model averaging. Mol. Biol. Evol. 25, 1253-1256.
31. Roussarie, J. P., C. Ruffie, and M. Brahic. 2007. The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog. 3, e23.
32. Sato, S., et al. 1996. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology 226, 327-337.
33. Sayle, R. A., and E. J. Milner-White. 1995. RASMOL, biomolecular graphics for all. Trends Biochem. Sci. 20, 374.
34. Stavrou, S., Z. Feng, S. M. Lemon, and R. P. Roos. 2010. Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway. J. Virol. 84, 9181-9189.
35. Takano-Maruyama, M., Y. Ohara, K. Asakura, and T. Okuwa. 2006. Theiler's murine encephalomyelitis virus leader protein amino acid residue 57 regulates subgroup-specific virus growth on BHK-21 cells. J. Virol. 80, 12025-12031.
36. Theiler, M. 1937. Spontaneous encephalomyelitis of mice, a new virus disease. J. Exp. Med. 65, 705-719.
37. Theiler, M., and S. Gard. 1940. Encephalomyelitis of mice. I. Characteristics and pathogenesis of the virus. J. Exp. Med. 72, 49-67.
38. van Eyll, O., and T. Michiels. 2002. Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence. J. Virol. 76, 10665-10673.
39. van Pesch, V., O. van Eyll, and T. Michiels. 2001. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J. Virol. 75, 7811-7817.
40. Wada, Y., I. J. McCright, F. G. Whitby, I. Tsunoda, and R. S. Fujinami. 1998. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination. J. Virol. 72, 7557-7562.
41. Wada, Y., M. L. Pierce, and R. S. Fujinami. 1994. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J. Virol. 68, 1219-1223.
42. Zhou, L., X. Lin, T. J. Green, H. L. Lipton, and M. Luo. 1997. Role of sialyloligosaccharide binding in Theiler's virus persistence. J. Virol. 71, 9701-9712.
43. Zhou, L., Y. Luo, Y. Wu, J. Tsao, and M. Luo. 2000. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 74, 1477-1485.
44. Zoll, J., et al. 2009. Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog. 5, e1000416.
45. Zurbriggen, A., C. Thomas, M. Yamada, R. P. Roos, and R. S. Fujinami. 1991. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J. Virol. 65, 1929-1937.